XML 36 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating activities:    
Net income $ 16,367,123 $ 13,448,125
Adjustments to reconcile net income to net cash provided by operating activities:    
Net amortization/accretion of premium/discount on securities 957,133 988,811
Depreciation and amortization 2,258,990 2,432,535
Provision for loan losses 487,638 2,172,404
Gain on mortgage loans sold, net (952,222) (1,813,488)
Stock-based compensation expense 1,201,111 962,969
Deferred tax benefit (16,406) (698,661)
(Gains) losses on dispositions of other real estate and other investments 13,112 (866,306)
Excess tax benefit from stock compensation (1,099,570) (28,628)
Mortgage loans held for sale:    
Loans originated (61,458,365) (107,845,659)
Loans sold 61,290,000 120,569,000
Decrease in other assets 527,594 3,050,703
Decrease in other liabilities (6,576,105) (8,339,670)
Net cash provided by operating activities 13,000,033 24,032,135
Activities in securities available-for-sale:    
Purchases (57,753,116) (65,204,465)
Sales 0 0
Maturities, prepayments and calls 23,192,675 43,551,916
Activities in securities held-to-maturity:    
Purchases 0 0
Maturities, prepayments and calls 860,000 75,868
Increase in loans, net (40,306,647) (63,167,119)
Purchases of software, premises and equipment (604,626) (1,442,076)
Purchase of bank owned life insurance 0 (30,000,000)
Increase in other investments (2,216) (303,750)
Net cash used in investing activities (74,613,930) (116,489,626)
Financing activities:    
Net decrease in deposits (32,895,938) (112,293,132)
Net increase (decrease) in securities sold under agreements to repurchase (2,372,676) 14,432,033
Advances from Federal Home Loan Bank:    
Issuances 175,000,000 240,000,000
Payments/maturities (115,016,116) (115,036,641)
Decrease in other borrowings (625,000) (625,000)
Exercise of common stock options and stock appreciation rights, net of repurchase of restricted shares 1,247,220 222,200
Excess tax benefit from stock compensation 1,099,570 28,628
Common stock dividends paid (2,824,493) 0
Net cash provided by financing activities 23,612,567 26,728,088
Net decrease in cash and cash equivalents (38,001,330) (65,729,403)
Cash and cash equivalents, beginning of period 208,938,737 165,288,669
Cash and cash equivalents, end of period $ 170,937,407 $ 99,559,266